Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

REGULUS THERAPEUTICS INC.

(RGLS)
  Report
Real-time Estimate Cboe BZX  -  02:21 2022-10-05 pm EDT
1.845 USD   +1.37%
09/12Regulus Therapeutics Says Kidney Disease Drug Showed Favorable Safety Profile in Phase 1 Study
MT
09/12Regulus Therapeutics Announces Positive Topline Safety and Pharmacokinetic (PK) Data from the Phase 1 Single-Ascending Dose (SAD) Clinical Trial of RGLS8429 for the treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
PR
09/12Regulus Therapeutics Inc. Announces Positive Topline Safety and Pharmacokinetic Data from the Phase 1 Single-Ascending Dose Clinical Trial of Rgls8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Event chart REGULUS THERAPEUTICS INC.
Upcoming events on REGULUS THERAPEUTICS INC.
11/10/22 Q3 2022 Earnings Release (Projected)
03/08/23 FY 2022 Earnings Release (Projected)
05/11/23 Q1 2023 Earnings Release (Projected)
08/10/23 Interim 2023 Earnings Release (Projected)
Past events on REGULUS THERAPEUTICS INC.
09/12/22 | 02:30pm H.C. Wainwright Global Investment Conference
09/07/22 Wells Fargo Healthcare Conference
08/11/22 | 05:00pm Interim 2022 Earnings Call
08/11/22 | 04:10pm Interim 2022 Earnings Release
06/29/22 REVERSE SPLIT: 1 of 10
06/09/22 | 12:00pm Annual General Meeting
05/24/22 | 07:00am H.C. Wainwright Global Life Sciences Investment Conference
05/12/22 | 05:00pm Q1 2022 Earnings Call
05/12/22 | 04:05pm Q1 2022 Earnings Release
04/12/22 Wells Fargo Biotech Forum
Past dividends on REGULUS THERAPEUTICS INC.

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread
0,07
0,11
-32%
0,07
3,57
-98%
6,83
6,86
-0,38%
10,0
5,02
99%


 
 

 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-70,1
-70,8
0,88%
-46,8
-43,0
-8,7%
-16,8
-17,2
2,2%
-14,2
-19,2
26%
-27,8
-27,4
-1,4%
 
-28,1
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-72,1
-72,3
0,25%
-48,6
-44,8
-8,6%
-18,6
-18,9
1,9%
-15,7
-20,9
25%
-27,8
-26,9
-3,4%
 
-28,6
 
Net income
M $
Released
Forecast
Spread
-71,9
-72,2
0,37%
-48,7
-44,8
-8,7%
-18,6
-18,9
1,9%
-15,7
-20,9
25%
-27,8
-26,9
-3,4%
 
-28,6
 
EPS
$
Released
Forecast
Spread
-115
-120
4,2%
-55,9
-33,3
-68%
-10,8
-11,0
1,8%
-4,50
-6,60
32%
-3,20
-3,27
2,0%
 
-1,71
 
Announcement Date03/07/201803/18/201903/12/202003/09/202103/10/2022-
Quarterly results
Fiscal Period : December2021 Q22021 Q32021 Q42022 Q12022 Q22022 Q3
Sales
M $
Released
Forecast
Spread

0,01
 

0,00
 


 


 


 
 

 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-6,64
-5,88
-13%
-8,42
-6,50
-30%
-6,96
-6,57
-5,9%
-6,57
-7,21
8,8%
-7,18
-7,05
-1,8%
 
-7,20
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-6,03
-6,03
-0,12%
-8,63
-6,31
-37%
-7,13
-6,14
-16%
-6,72
-7,20
6,7%
-7,26
-7,14
-1,7%
 
-7,29
 
Net income
M $
Released
Forecast
Spread
-6,03
-6,03
-0,14%
-8,63
-6,31
-37%
-7,13
-6,14
-16%
-6,72
-7,20
6,7%
-7,26
-7,14
-1,7%
 
-7,29
 
EPS
$
Released
Forecast
Spread
-0,80
-0,80
0,00%
-1,00
-0,78
-29%
-0,70
-0,67
-5,0%
-0,50
-0,53
6,2%
-0,50
-0,49
-3,1%
 
-0,48
 
Announcement Date08/10/202111/10/202103/10/202205/12/202208/11/2022-
Previous year Next Year
Upcoming sector events for REGULUS THERAPEUTICS INC.
More events
Past sector events for REGULUS THERAPEUTICS INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise